Holen Sie sich die Stockscreener-App
275.12
1.79%
-5.01
Handel nachbörslich:
276.11
0.99
+0.36%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SYK?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$280.13
Offen:
$278.02
24-Stunden-Volumen:
4.78M
Relative Volume:
1.88
Marktkapitalisierung:
$105.53B
Einnahmen:
$25.27B
Nettoeinkommen (Verlust:
$3.34B
KGV:
31.87
EPS:
8.6334
Netto-Cashflow:
$4.57B
1W Leistung:
-0.16%
1M Leistung:
-16.97%
6M Leistung:
-20.44%
1J Leistung:
-27.19%
1-Tages-Spanne:
$274.37
$279.26
1-Wochen-Bereich:
$274.37
$290.51
52-Wochen-Spanne:
$267.00
$392.55
Stryker Corp Stock (SYK) Company Profile
Firmenname
Stryker Corp
Sektor
Branche
Telefon
(269) 385-2600
Adresse
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
275.12 | 105.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
ABT
Abbott Laboratories
|
102.61 | 176.41B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.13 | 116.35B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
43.34 | 62.29B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.26 | 48.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Leerink Partners | Outperform |
| 2026-02-20 | Eingeleitet | William Blair | Outperform |
| 2026-01-27 | Fortgesetzt | TD Cowen | Hold |
| 2026-01-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Fortgesetzt | Citigroup | Buy |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Outperform |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-22 | Hochstufung | Needham | Hold → Buy |
| 2024-01-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-25 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-28 | Hochstufung | Edward Jones | Hold → Buy |
| 2022-07-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-13 | Eingeleitet | Truist | Hold |
| 2022-03-16 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-07-28 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Underweight |
| 2020-10-06 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Herabstufung | Goldman | Buy → Sell |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Hold |
| 2020-01-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Bestätigt | BTIG Research | Buy |
| 2019-11-05 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Bestätigt | BofA/Merrill | Buy |
| 2019-07-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Bestätigt | Canaccord Genuity | Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-16 | Eingeleitet | BTIG Research | Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-27 | Bestätigt | Stifel | Buy |
Alle ansehen
Stryker Corp Aktie (SYK) Neueste Nachrichten
Stryker Corp rStock (RSYK) Price Prediction for 2026 to 2031 - bybit.com
Stryker Corp. stock extends slide as analysts trim targets but keep buy ratings - ad-hoc-news.de
Law firm probes Stryker for possible securities law breaches after conflicting manufacturing updates. - Pluang
Stryker stock heads into the open after a 1.95% drop - ad-hoc-news.de
Stryker Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Stryker stock falls on slower peripheral vascular, hip sales - MedTech Dive
Stryker Corporation $SYK Shares Acquired by Tidal Investments LLC - MarketBeat
WINTON GROUP Ltd Grows Position in Stryker Corporation $SYK - MarketBeat
BMO cuts Stryker stock price target on revised estimates to $317 By Investing.com - Investing.com Australia
NJ Electrical Manufacturer Taps Longtime Stryker Atty As GC - Law360
BMO cuts Stryker stock price target on revised estimates to $317 - Investing.com Nigeria
Stryker To Acquire ZuriMED To Expand Shoulder And Rotator Cuff Portfolio - Pulse 2.0
Stryker acquires Swiss firm to expand shoulder repair business - Crain's Grand Rapids
Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating - marketscreener.com
Is Stryker (NYSE:SYK) a stock worth watching as trading resumes? - Kalkine Media
Wells Fargo cuts Stryker stock price target on revenue concerns By Investing.com - Investing.com India
Stryker Stock Drops Over 7% As Supply Chain Constraints Impact Peripheral Vascular Business - TIKR.com
Duke Health, Stryker put augmented reality to work in hip surgery - modernhealthcare.com
Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating - marketscreener.com
BMO Capital Adjusts Price Target on Stryker to $317 From $369, Keeps Outperform Rating - marketscreener.com
Stryker (NYSE:SYK) Sets New 12-Month LowShould You Sell? - MarketBeat
A 6-Day Losing Streak Has Stryker Stock Down 16% - Trefis
Baird Financial Group Inc. Sells 5,319 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Stock Declines as Manufacturing Issues Continue - Moomoo
United StatesMintz Advises ZuriMED Shareholders In Acquisition By Stryker - Mondaq
533,784 Shares in Stryker Corporation $SYK Purchased by Veritas Asset Management LLP - marketbeat.com
Is Stryker Corp (SYK) a Bargain After 8.8% Drop? GF Value Says U - GuruFocus
Stryker Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
SYK ALERT: Stryker Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm - GlobeNewswire
Stryker (NYSE: SYK) VP, controller discloses 5,538 stock options - Stock Titan
Cyberattacks Hit Boston Scientific and Stryker, Clouding Outlooks - Briefs Finance
Supply chain woes send Stryker stock tumbling 7.7% - investing.com
Stryker (NYSE:SYK) Shares Down 6.2%What's Next? - MarketBeat
Stryker at wells fargo healthcare conference: growth tested by supply - Investing.com Canada
Supply chain woes send Stryker stock tumbling 7.7% By Investing.com - Investing.com India
Boston Scientific Unlikely to Meet Forecasts After Cyber Attack - Bloomberg.com
Why Stryker (SYK) Stock Is Down Today - Quiver Quantitative
Stryker stock drops after CFO remarks (SYK:NYSE) - Seeking Alpha
Stryker Corporation stock hits 52-week low at 280.99 USD - investing.com
Stryker Corp. stock gains on stronger earnings and raised guidance - ad-hoc-news.de
Agilent Names Dow Wilson Board Chair, Adds Former Stryker CFO Glenn Boehnlein - citybiz
Stryker (SYK) Stock Could Be 28% Undervalued After A Shoulder Tech Deal - simplywall.st
Why Stryker (NYSE:SYK) Is in Focus After the NYSE Reopens? - Kalkine Media
Stryker Corporation $SYK Stock Position Lifted by Amundi - marketbeat.com
Stryker stock gains after a revenue beat and higher guidance - ad-hoc-news.de
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
HighTower Advisors LLC Has $153.01 Million Stake in Stryker Corporation $SYK - marketbeat.com
Stryker Corporation (SYK) Stock Analysis: Exploring a 26% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews
Hsbc Holdings PLC Raises Stock Position in Stryker Corporation $SYK - marketbeat.com
Stryker Corporation $SYK Shares Purchased by California State Teachers Retirement System - marketbeat.com
Saudi Central Bank Has $7.60 Million Stock Position in Stryker Corporation $SYK - MarketBeat
Finanzdaten der Stryker Corp-Aktie (SYK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Stryker Corp-Aktie (SYK) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| STRYKER RONDA E | Director |
Aug 18 '26 |
Sale |
335.90 |
300,000 |
100,770,963 |
2,301,375 |
| STRYKER RONDA E | Director |
Aug 19 '26 |
Sale |
340.10 |
50,000 |
17,005,165 |
2,251,375 |
| King Debra | See Remarks |
Aug 18 '26 |
Sale |
336.30 |
826 |
277,787 |
6,210 |
0.69%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):